Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is characterized by the activation of a
cytokine storm derived from an excess release of
cytokine (
interleukin [IL]-6,
interferon [IFN] I, C-X-C motif
chemokine ligand [CXCL]10,
tumor necrosis factor [TNF]-α,
macrophage inflammatory protein [MIP]1) due to an uncontrolled immune activation. There has been a fivefold increase in the number of cases of
pityriasis rosea during the SARS-CoV-2 pandemic. Using the keywords "
pityriasis" and "
COVID-19", we carried out a PubMed search, including all articles in the English language published until November 2021. We aimed to investigate the possible connection between SARS-CoV-2 and
pityriasis rosea (PR).
Pityriasis could be considered an
immunological disease due to the involvement of
cytokines and
chemokines. Our analysis yielded 65 articles of which 53 were not considered; the others (n = 12) concerning the association between PR and
COVID-19 were included in our study. We suggest two mechanisms underlying the involvement of the skin in
viral infections: (i) viruses directly affecting the skin and/or inducing host immune response thus causing cutaneous manifestations; and (ii) viruses as a possible inducer of the reactivation of another virus. The first mechanism is probably related to a release of pro-inflammatory
cytokine and
infection-related
biomarkers; in the second, several pathways could be involved in the reactivation of other latent viruses (human herpesviruses 6 and 7), such as a
cytokine-
cytokine receptor interaction, the
Janus kinase-signal transducer and activator of transcription signaling pathway, and the
IL-17 signaling pathway. We thus believe that a
cytokine storm could be directly or indirectly responsible for a cutaneous manifestation. More investigations are needed to find specific pathways involved and thus confirm our speculations.